Bioedeucator is a media partner of CE Bioforum 2024
For over two decades, BioForum has been a meeting point for leaders in the biotechnology industry, scientists, entrepreneurs, and students interested in the latest trends and innovations. CEBioForum2024 is international and conducted in English. This year’s program includes:
- Interesting panel discussions: Cell & gene therapy; How to handle Biomanufacturing?; How to enter US market?; How to prepare your company for clinical trials?; 5 steps of commercialization; How to build your biotech company from scratch?; Building Bridges – how to enter UK market; How to raise funds for your biotech company – IPO vs. VC?
- Company Presentations
- Exhibition Stands
- B2B Meetings: A dedicated application will facilitate business meetings, fostering networking.
- Gala Awards Ceremony CEBioForum Awards 2024
- Evening Networking Banquet
BioForum not only connects scientists with business representatives but also provides an opportunity to present research projects and discuss the sector’s most significant challenges and opportunities. We encourage you to nominate candidates for CEBioForum Awards in 4 categories, including R&D collaboration, Innovative Start-up, Most Influencing Person, and Jury Award.
The deadline for submissions is March 8, 2024. NOMINATE A CANDIDATE FOR CEBioForum Awards
Do you want to gain new knowledge, establish valuable contacts, and contribute to shaping the future of the biotechnology sector?
Meet industry professionals from around the world at CEBioForum 2024! BUY A TICKET
Stay updated with fresh news about the conference and the latest achievements in the biotechnology industry on social media using #CEBioForum na LinkedIn / Twitter / Fb!
Upcoming Trainings
Trainings Calendar
- MO
- TU
- WE
- TH
- FR
- SA
- SU
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 1
- 2
- 3
- 4
- 5
- Quality by Design in Drug Products Development
Share! Facebook LinkedIn Twitter Quality by design (QbD) is a concept that has become firmly established in the pharmaceutical and biotechnology world. The ICH, FDA and EMA have been working on the implementation of QbD in the life cycle of medicinal products for many years, resulting in the ICH Q8, Q9 and Q10 guidelines. However,… - Fault Tree Analysis
Risk analysis is an integral part of working in the pharma and biotech industry. The ICH Q9 guideline describes exactly what it is used for and what risk analysis tools are proposed. Some of the most popular are FMEA, RRF, PHA, Ishigava diagram, HACCP etc. A few months ago, for a consulting project, I started…
